![Clemens M. Doppler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clemens M. Doppler
Président chez
4SC AG
Profil
Clemens M.
Doppler is currently the Chairman-Supervisory Board at 4SC AG since 2014.
He is also the Chairman at MerLion Pharmaceuticals Pte Ltd., Chairman-Supervisory Board at MerLion Pharmaceuticals GmbH, Director at Merlion Trade GmbH, Managing Director at Heidelbergcapital General Partner GmbH since 2008, Managing Partner at HeidelbergCapital Asset Management GmbH since 2008, Member at DVFA e.V., and Member-Supervisory Board at Verinos Pharmaceuticals GmbH.
In his former positions, Dr. Doppler served as the Chairman at Accovion GmbH from 2008 to 2015.
He was also the Vice Chairman-Supervisory Board at Sensovation AG from 2001 to 2013.
Additionally, he worked as the Business Development Director & Head-department at Phoenix International Life Sciences, Inc. from 1994 to 2000, and as the Director-Business Development & Head-department at Phoenix International Life Sciences, Inc. (Switzerland) during the same period.
Furthermore, he held the position of Investment Manager at 3i Group Plc from 2000 to 2007.
He also served as an Investment Manager at Technologie Holding and as a Member-Supervisory Board at vasopharm GmbH and Nanogate SE.
Dr. Doppler obtained his graduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.
Postes actifs de Clemens M. Doppler
| Sociétés | Poste | Début |
|---|---|---|
| 4SC AG | Président | 19/09/2014 |
MerLion Pharmaceuticals GmbH
 MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine | Président | - |
Heidelbergcapital General Partner GmbH | Directeur Général | 01/01/2008 |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics | Président | 01/01/2006 |
DVFA e.V. | Corporate Officer/Principal | - |
HeidelbergCapital Asset Management GmbH
 HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake. | Private Equity Investor | 01/01/2008 |
Verinos Pharmaceuticals GmbH
 Verinos Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops drugs for brain injuries | Directeur/Membre du Conseil | - |
Anciens postes connus de Clemens M. Doppler
| Sociétés | Poste | Fin |
|---|---|---|
Merlion Trade GmbH | Directeur/Membre du Conseil | 23/01/2021 |
Accovion GmbH
 Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Président | 01/01/2015 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Clemens M. Doppler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Phoenix International Life Sciences, Inc.
 Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioanalytical research and clinical testing services | Commercial Services |
3i Group Plc
 3i Group Plc Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Technologie Holding
 Technologie Holding Financial ConglomeratesFinance Provides Internet investment services | Finance |
Accovion GmbH
Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensovation AG
 Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets scientific imaging instrumentation technologies | Electronic Technology |
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics | Health Technology |
Nanogate SE
 Nanogate SE Industrial MachineryProducer Manufacturing Designs, develops and produces composite and surface treatments | Producer Manufacturing |
HeidelbergCapital Asset Management GmbH
HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake. | Finance |
Merlion Trade GmbH | |
DVFA e.V. | |
MerLion Pharmaceuticals GmbH
MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine | Commercial Services |
Heidelbergcapital General Partner GmbH | |
Phoenix International Life Sciences,Inc. (Switzerland) | |
Verinos Pharmaceuticals GmbH
Verinos Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops drugs for brain injuries | Health Technology |
